Literature DB >> 33151298

GRNdb: decoding the gene regulatory networks in diverse human and mouse conditions.

Li Fang1, Yunjin Li1, Lu Ma1, Qiyue Xu1, Fei Tan2, Geng Chen1,3.   

Abstract

Gene regulatory networks (GRNs) formed by transcription factors (TFs) and their downstream target genes play essential roles in gene expression regulation. Moreover, GRNs can be dynamic changing across different conditions, which are crucial for understanding the underlying mechanisms of disease pathogenesis. However, no existing database provides comprehensive GRN information for various human and mouse normal tissues and diseases at the single-cell level. Based on the known TF-target relationships and the large-scale single-cell RNA-seq data collected from public databases as well as the bulk data of The Cancer Genome Atlas and the Genotype-Tissue Expression project, we systematically predicted the GRNs of 184 different physiological and pathological conditions of human and mouse involving >633 000 cells and >27 700 bulk samples. We further developed GRNdb, a freely accessible and user-friendly database (http://www.grndb.com/) for searching, comparing, browsing, visualizing, and downloading the predicted information of 77 746 GRNs, 19 687 841 TF-target pairs, and related binding motifs at single-cell/bulk resolution. GRNdb also allows users to explore the gene expression profile, correlations, and the associations between expression levels and the patient survival of diverse cancers. Overall, GRNdb provides a valuable and timely resource to the scientific community to elucidate the functions and mechanisms of gene expression regulation in various conditions.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2021        PMID: 33151298     DOI: 10.1093/nar/gkaa995

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  8 in total

1.  Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer.

Authors:  Di Zhang; Liping Ye; Shuang Hu; Qingqing Zhu; Chenxi Li; Chengming Zhu
Journal:  J Immunol Res       Date:  2022-06-06       Impact factor: 4.493

2.  TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.

Authors:  Wen Gao; Zhe-Wen Zhang; Hong-Yi Wang; Xin-Di Li; Wei-Ting Peng; Hao-Yu Guan; Yu-Xuan Liao; An Liu
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

3.  Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis.

Authors:  Xu Feng; Ning Guan; Enshi Xu; Ye Miao; Chenguang Li
Journal:  Dis Markers       Date:  2021-12-30       Impact factor: 3.434

4.  Constructing gene regulatory networks using epigenetic data.

Authors:  Abhijeet Rajendra Sonawane; Dawn L DeMeo; John Quackenbush; Kimberly Glass
Journal:  NPJ Syst Biol Appl       Date:  2021-12-09

5.  Inferring causal gene regulatory network via GreyNet: From dynamic grey association to causation.

Authors:  Guangyi Chen; Zhi-Ping Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-09-27

6.  A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells.

Authors:  Sarthak Sahoo; Ashutosh Mishra; Harsimran Kaur; Kishore Hari; Srinath Muralidharan; Susmita Mandal; Mohit Kumar Jolly
Journal:  NAR Cancer       Date:  2021-07-09

7.  GRAND: a database of gene regulatory network models across human conditions.

Authors:  Marouen Ben Guebila; Camila M Lopes-Ramos; Deborah Weighill; Abhijeet Rajendra Sonawane; Rebekka Burkholz; Behrouz Shamsaei; John Platig; Kimberly Glass; Marieke L Kuijjer; John Quackenbush
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

8.  Prediction of Disease Genes Based on Stage-Specific Gene Regulatory Networks in Breast Cancer.

Authors:  Linzhuo Fan; Jinhong Hou; Guimin Qin
Journal:  Front Genet       Date:  2021-07-15       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.